Effect of the Atherogenic Index of Plasma on Microvascular Complications Associated with Type 2 Diabetes Mellitus

dc.authorid0000-0001-7213-9624
dc.authorid0000-0001-7213-9624
dc.authorwosidBOYUK, BANU/ABA-7026-2021
dc.authorwosiderman, hande/AAP-6507-2021
dc.authorwosiderman, hande/AAZ-7697-2021
dc.contributor.authorAtalay, Hande
dc.contributor.authorBoyuk, Banu
dc.contributor.authorDeğirmencioğlu, Şerife
dc.contributor.authorGüzel, Savaş
dc.contributor.authorÇelebi, Aslan
dc.contributor.authorEkizoğlu, İsmail
dc.date.accessioned2022-05-11T14:42:05Z
dc.date.available2022-05-11T14:42:05Z
dc.date.issued2015
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalı
dc.description.abstractObjective: The aim of this study was to evaluate the effects of the atherogenic index of plasma (AIP) on the microvascular complications of type 2 diabetes mellitus (DM) patients who applied to our internal medicine clinic. Methods: The study included 212 type 2 DM patients and 34 healthy controls who were compatible according to age and sex. Age, sex, duration of illness, treatment for diabetes and other illnesses associated with diabetes, height, weight, retinopathy, nephropathy, neuropathy, hypertension, and hyperlipidemia were recorded at the beginning of the study. AIP is calculated as the logarithm of the ratio between the triglyceride value and high density lipoprotein value (in mg/dL). Results: AIP and triglyceride levels of the type 2 DM patients were higher than those of the control group. Also, the study determined that 25.7% of the patients have retinopathy, 31.6% have neuropathy, 29.1% have microalbuminuria, and 3.9% have macroalbuminuria. If we accept that there is a complications who have one of these complications in this three, there is 62.6% of the patients have complications. A statistically significant correlation was determined with these complications and lipid subgroups such as AIP and low density lipoprotein (LDL). Conclusion: The relationship between AIP and only nephropathy, which is a complication in type 2 DM patients, was determined.
dc.identifier.doi10.5152/imj.2015.05902
dc.identifier.endpage115
dc.identifier.issn2619-9793
dc.identifier.issn2148-094X
dc.identifier.issue3en_US
dc.identifier.startpage111
dc.identifier.urihttps://doi.org/10.5152/imj.2015.05902
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9211
dc.identifier.volume16
dc.identifier.wosWOS:000421133400006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorGüzel, Savaş
dc.language.isoen
dc.publisherIstanbul Training & Research Hospital
dc.relation.ispartofIstanbul Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDiabetes
dc.subjectmicrovascular complication
dc.subjectatherogenic index
dc.subjectEsterification Rate
dc.subjectRisk-Factors
dc.subjectRetinopathy
dc.subjectProgression
dc.subjectCholesterol
dc.subjectFenofibrate
dc.subjectNeuropathy
dc.subjectIntervention
dc.subjectStatins
dc.subjectDisease
dc.titleEffect of the Atherogenic Index of Plasma on Microvascular Complications Associated with Type 2 Diabetes Mellitus
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
9211.pdf
Boyut:
79.71 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text